Your browser doesn't support javascript.
loading
Sphingosine Kinase 2 Inhibition and Blood Sphingosine 1-Phosphate Levels.
Kharel, Yugesh; Morris, Emily A; Congdon, Molly D; Thorpe, Steven B; Tomsig, Jose L; Santos, Webster L; Lynch, Kevin R.
Afiliação
  • Kharel Y; Department of Pharmacology, University of Virginia, Charlottesville, Virginia (Y.K., J.L.T., K.R.L.); Department of Chemistry and Virginia Tech Center for Drug Discovery, Virginia Tech, Blacksburg, Virginia (E.A.M., M.D.C., W.L.S.); and SphynKx Therapeutics LLC, Charlottesville, Virginia (S.B.T.) yk
  • Morris EA; Department of Pharmacology, University of Virginia, Charlottesville, Virginia (Y.K., J.L.T., K.R.L.); Department of Chemistry and Virginia Tech Center for Drug Discovery, Virginia Tech, Blacksburg, Virginia (E.A.M., M.D.C., W.L.S.); and SphynKx Therapeutics LLC, Charlottesville, Virginia (S.B.T.).
  • Congdon MD; Department of Pharmacology, University of Virginia, Charlottesville, Virginia (Y.K., J.L.T., K.R.L.); Department of Chemistry and Virginia Tech Center for Drug Discovery, Virginia Tech, Blacksburg, Virginia (E.A.M., M.D.C., W.L.S.); and SphynKx Therapeutics LLC, Charlottesville, Virginia (S.B.T.).
  • Thorpe SB; Department of Pharmacology, University of Virginia, Charlottesville, Virginia (Y.K., J.L.T., K.R.L.); Department of Chemistry and Virginia Tech Center for Drug Discovery, Virginia Tech, Blacksburg, Virginia (E.A.M., M.D.C., W.L.S.); and SphynKx Therapeutics LLC, Charlottesville, Virginia (S.B.T.).
  • Tomsig JL; Department of Pharmacology, University of Virginia, Charlottesville, Virginia (Y.K., J.L.T., K.R.L.); Department of Chemistry and Virginia Tech Center for Drug Discovery, Virginia Tech, Blacksburg, Virginia (E.A.M., M.D.C., W.L.S.); and SphynKx Therapeutics LLC, Charlottesville, Virginia (S.B.T.).
  • Santos WL; Department of Pharmacology, University of Virginia, Charlottesville, Virginia (Y.K., J.L.T., K.R.L.); Department of Chemistry and Virginia Tech Center for Drug Discovery, Virginia Tech, Blacksburg, Virginia (E.A.M., M.D.C., W.L.S.); and SphynKx Therapeutics LLC, Charlottesville, Virginia (S.B.T.).
  • Lynch KR; Department of Pharmacology, University of Virginia, Charlottesville, Virginia (Y.K., J.L.T., K.R.L.); Department of Chemistry and Virginia Tech Center for Drug Discovery, Virginia Tech, Blacksburg, Virginia (E.A.M., M.D.C., W.L.S.); and SphynKx Therapeutics LLC, Charlottesville, Virginia (S.B.T.).
J Pharmacol Exp Ther ; 355(1): 23-31, 2015 Oct.
Article em En | MEDLINE | ID: mdl-26243740
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esfingosina / Lisofosfolipídeos / Fosfotransferases (Aceptor do Grupo Álcool) / Inibidores Enzimáticos Limite: Animals Idioma: En Revista: J Pharmacol Exp Ther Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esfingosina / Lisofosfolipídeos / Fosfotransferases (Aceptor do Grupo Álcool) / Inibidores Enzimáticos Limite: Animals Idioma: En Revista: J Pharmacol Exp Ther Ano de publicação: 2015 Tipo de documento: Article